JA
Jeffrey Arcara bought $50K of CRVS stock
Jeffrey Arcara, Chief Business Officer of Corvus Pharmaceuticals, Inc. (CRVS), bought 4,500 shares of CRVS stock worth $50K, per an SEC Form 4 filed Nov 13, 2026.
It was an open-market purchase.
The trade happened on Nov 11, 2026, 2 days before it was made public.
CRVS has moved -7.4% since the trade date, from $11.47 to $10.62 (Nov 12, 2026 close).
- Traded
- Nov 11, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 2 days
- Price since
- -7.4%
- Role
- Chief Business Officer
- Source
- SEC Form 4